Neural plasticity and depression treatment-Reference-Cited by-全球学者库

Neural plasticity and depression treatment

Published:2023-06 Issue: Volume:14 Page:160-184
ISSN:2667-2421
Container-title:IBRO Neuroscience Reports
language:en
Short-container-title:IBRO Neuroscience Reports

Author:

Wang Yu-Bing,Song Ning-Ning,Ding Yu-Qiang,Zhang Lei

Publisher

Elsevier BV

Subject

General Neuroscience

Reference281 articles.

1. Prefrontal connectivity and glutamate transmission: relevance to depression pathophysiology and ketamine treatment;Abdallah;Biol. Psychiatry Cogn. Neurosci. Neuroimaging,2017

2. Ketamine treatment and global brain connectivity in major depression;Abdallah;Neuropsychopharmacology,2017

3. Involvement of the serotonergic system and neuroplasticity in the antidepressant effect of curcumin in ovariectomized rats: comparison with oestradiol and fluoxetine;Abd-Rabo;Phytother. Res.,2019

4. The neuropeptide cycloprolylglycine produces antidepressant-like effect and enhances BDNF gene expression in the mice cortex;Abdullina;J. Psychopharmacol.,2022

5. Dopaminergic enhancement of striatal response to reward in major depression;Admon;Am. J. Psychiatry,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural and biochemical alterations in dendritic spines as key mechanisms for severe mental illnesses;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-02

2. Pharmacokinetics, absolute bioavailability, and tissue distribution of WJ‐14, a novel N‐methyl‐d‐aspartate receptor antagonist, in rats by liquid chromatography–tandem mass spectrometry;Biomedical Chromatography;2024-01-22

3. Mechanisms of Sustained Increases in γ Power Post-Ketamine in a Computational Model of the Hippocampal CA3: Implications for Ketamine’s Antidepressant Mechanism of Action;Brain Sciences;2023-11-07

4. Designing multi-target drugs for the treatment of major depressive disorder;Expert Opinion on Drug Discovery;2023-05-19